Title: Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators
Authors: Vancampfort, Davy ×
Vansteelandt, Kristof
Correll, CU
Mitchell, AJ
De Herdt, Amber
Sienaert, Pascal
Probst, Michel
De Hert, Marc #
Issue Date: Mar-2013
Publisher: American Psychiatric Association
Series Title: American Journal of Psychiatry vol:170 issue:3 pages:265-274
Abstract: Objective: Patients with bipolar disorder have high levels of cardiovascular disease risk factors. The presence of metabolic syndrome significantly influences future
cardiovascular disease morbidity and mortality.
The authors sought to clarify the prevalence and moderators of metabolic syndrome in bipolar patients, accounting
for subgroup differences.
Method: The authors searched MEDLINE, PsycINFO, EMBASE, and CINAHL through April 2012 for research reporting metabolic
syndrome prevalence rates in bipolar patients. Medical subject headings “metabolic syndrome” and “bipolar” were
used in the title, abstract, or index term fields. Manual searches were conducted using the reference lists from identified articles.
Results: The search yielded 81 articles in 37 publications (N=6,983). The overall metabolic syndrome rate was 37.3% (95% confidence interval [CI]=36.1–39.0) using any standardized metabolic syndrome criteria. Compared with general population groups, bipolar patients had higher
metabolic syndrome rates (odds ratio=1.98; 95% CI=1.74–2.25). In bipolar patients, older age had a modest effect on the metabolic syndrome rate. The strongest moderator was the region in which the study took place, with the highest rates observed in New Zealand and Australia (64.2% [95% CI=38.3–83.9]) and North America (49.3% [95% CI=29.7–69.3]). Metabolic syndrome was significantly more
prevalent in patients currently treated with antipsychotics (45.3% [95% CI=39.6–50.9] than in patients who were antipsychotic free (32.4% [95% CI=27.5–37.4]; odds ratio=
1.72 [95% CI=1.24–2.38]).
Conclusions: These findings strongly support the claim that patients with bipolar disorder are at high risk for metabolic syndrome and related cardiovascular morbidity
and mortality and require regular monitoring and adequate preventive efforts and treatment for cardio-metabolic
risk factors. These findings further suggest that the risk of metabolic syndrome is greater in bipolar patients taking prescribed antipsychotic medication.
ISSN: 0002-953X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Research Group Psychiatry (-)
Research Group for Adapted Physical Activity and Psychomotor Rehabilitation
Department of Neurosciences - miscellaneous
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Vancampfort, metabolic syndrome.pdf Published 757KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science